Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.
United States Court of Appeals for the Federal Circuit
566 F.3d 989 (2009)
- Written by Samantha Arena, JD
Facts
Procter & Gamble Company (P&G) (plaintiff) held a patent for the compound risedronate, the active ingredient in P&G’s osteoporosis drug Actonel. Risedronate is a chemical compound known as a bisphosphonate, which is useful in inhibiting the breakdown of bone tissue. After conducting unsuccessful experiments with hundreds of bisphosphonate compounds, including 2-pyr EHDP and 4-pyr EHDP, P&G finally identified risedronate, or 3-pyr EHDP, as a potentially useful compound exhibiting unexpectedly effective attributes. P&G sued Teva Pharmaceuticals USA, Inc. (Teva) (defendant) for infringement of the risedronate patent after Teva communicated its plans to sell risedronate as Actonel’s generic equivalent. Teva contended that the patent was invalid as obvious based on a prior P&G patent listing 2-pyr EHDP as a candidate for treatment of osteoporosis, because 2-pyr EHDP and risedronate were structurally similar. At trial, P&G presented expert testimony establishing that, at the time, the properties of bisphosphonates were highly unpredictable and could not be anticipated based on their structure. The district court found in P&G’s favor, concluding that the patent was valid. Teva appealed.
Rule of Law
Issue
Holding and Reasoning (Huff, J.)
What to do next…
Here's why 811,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,300 briefs, keyed to 988 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.